Get the Stockscreener App
2.5273
2.42%
-0.0627
Psyence Biomedical Ltd stock is traded at $2.5273, with a volume of 6,907.
It is down -2.42% in the last 24 hours and down -12.55% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$2.59
Open:
$2.57
24h Volume:
6,907
Relative Volume:
0.02
Market Cap:
$2.57M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.54%
1M Performance:
-12.55%
6M Performance:
-84.97%
1Y Performance:
-94.43%
1-Day Range:
$2.48
$2.57
1-Week Range:
$2.3001
$2.68
52-Week Range:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
2.51 | 2.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.70 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
721.77 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.03 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.37 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Psyence Biomedical Ltd Stock (PBM) Latest News
How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru
Psyence Biomed announces export of GMP-manufactured natural psilocybin (NPX-5) to Australia for ongoing clinical trial phase IIb - marketscreener.com
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial - The Manila Times
Natural psilocybin shipped to Australia for cancer palliative care trial - Stock Titan
Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes - TipRanks
Large share exchange boosts Psyence Labs’ stake in Psyence Biomedical (PBM) - Stock Titan
VIX Spike: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn
Aug EndMonth: Can Psyence Biomedical Ltd Equity Warrant beat the S P 5002025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyGap Down & Accurate Technical Buy Alerts - mfd.ru
PBM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PBM Earnings History & Surprises | EPS & Revenue Results | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
PBM PE Ratio & Valuation, Is PBM Overvalued - Intellectia AI
Movement Recap: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Psyence Biomedical shares rise following equity investment agreement - MSN
Psyence BioMed Announces Exercise Of Put Option By Psyence Labs; Stock Up - Nasdaq
Psyence Biomedical stock gains on equity investment deal By Investing.com - Investing.com Canada
Aug Rallies: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Trade Ideas & AI Forecast Swing Trade Picks - baoquankhu1.vn
Is Psyence Biomedical Ltd.’s ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - mfd.ru
Psyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction Breakthrough - MSN
Psyence BioMed Exercises Put Option to Invest in PsyLabs - Intellectia AI
Psyence Biomedical Cedes 49.98% Stake to PsyLabs in US$5 Million Share Swap - TipRanks
Psyence Biomedical Ltd. Invests in Psyence Labs Ltd. to Enhance Strategic Relationship and Supply Chain Capabilities - Quiver Quantitative
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment - The Spec
Psyence Biomedical Shareholders Approve Board, Auditor and Share Consolidation Authority - The Globe and Mail
PBM SEC FilingsPsyence Biomedical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
Does Psyence Biomedical Ltd. stock have upside surprise potential2025 Buyback Activity & Reliable Entry Point Trade Alerts - mfd.ru
Weiner discloses 51,850-share, 5.07% stake in Psyence Biomedical (PBM) - Stock Titan
Growth Review: Does Bitfarms Ltd align with a passive investing strategyTrade Performance Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn
Will Psyence Biomedical Ltd. outperform its industry peersMarket Sentiment Report & Precise Trade Entry Recommendations - mfd.ru
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders - Bitget
Psyence Biomedical Ltd. Announces Shareholder Meeting Results, Directors Elected and Share Consolidation Authority Granted - Quiver Quantitative
Psilocybin developer’s investors back plan to combine shares up to 250-for-1 - Stock Titan
Sectors Review: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Weekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025Oil Prices & AI Forecast for Swing Trade Picks - mfd.ru
Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - The Globe and Mail
PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks
Psyence BioMed Enters Put Option Agreement with PsyLabs - Intellectia AI
Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - The Spec
Psyence BioMed Approves Put Option Agreement With PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - 富途牛牛
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks
Activity Recap: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsIPO Watch & AI Forecasted Entry/Exit Points - baoquankhu1.vn
PSYENCE BIOMEDICAL LTD TO PAY KAOS CAPITAL $1.5 MILLION IN SETTLEMENT - Intellectia AI
Psyence Biomedical announces settlement of shareholder litigation - TipRanks
Psyence Biomed announces settlement of shareholder litigation - marketscreener.com
Psyence Biomedical Ltd. Reaches Settlement Agreement with KAOS Capital Ltd. to Resolve Shareholder Claims - Quiver Quantitative
Psyence BioMed Announces Settlement of Shareholder Litigation - ChartMill
Published on: 2026-02-11 15:38:29 - mfd.ru
Is Psyence Biomedical Ltd. stock forming a triangle patternWeekly Trend Recap & Risk Managed Investment Signals - mfd.ru
Revenue Check: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500July 2025 Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Final Week: Is Xenon Pharmaceuticals Inc a play on infrastructure spendingBond Market & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Psyence Biomedical Ltd Stock (PBM) Financials Data
There is no financial data for Psyence Biomedical Ltd (PBM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):